Topics:
Radiation Oncology • Genitourinary Cancers
Is 80 Gy/40 Fx + ADT the new standard of care for definitive radiation of high risk prostate cancer?
GETUG-AFU 18 has shown a survival benefit over 70 Gy. There is much pressure to hypofractionate, but this is the first study showing a survival benefit with dose escalation with conventional fractionation.
Answer from: Radiation Oncologist at Community Practice
@Simul, All data points to dose (i.e., BED) mattering for higher risk CaP. That said, for amenable patients, I dose-escalate via brachy-boost following EBRT in my practice as per ASCENDE. For non-brachy candidates being treated with definitive beam, I had recently switched from standard fx 80 G...
Comments
Radiation Oncologist at Vanderbilt-Ingram Cancer Center
Your BED calculations suggest that you are using a...
Your BED calculations suggest that you are using a...
Radiation Oncologist at Vice Chair, Northside Hospital Cancer Institute
Great point. Using the a/b of 1.5 accepted for pro...
Great point. Using the a/b of 1.5 accepted for pro...
Radiation Oncologist at Vanderbilt-Ingram Cancer Center
For what it's worth, I wouldn't expect the a/b to ...
For what it's worth, I wouldn't expect the a/b to ...
You are the best
Thank you!
Nicely put, @Dan. Lots of questions. But, also, cl...
Your answers are always very helpful and well done
What are your thoughts on the benefit of adding 2n...
This!!
Hi @Dan, your answer is solid and very helpful. As...